Min-Hee Ryu

27PUBLICATIONS
112CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 07, 2026
Phase 1/1b open-label, first-in-human study of HER2×CD3×CD28 trispecific T-cell engager (SAR443216) in participants with R/R HER2-expressing solid tumors.

|Jun 09, 2026
A Phase Ib/IIa Study of Fostrox in Combination with Lenvatinib as Second-line Therapy in Patients with Advanced Hepatocellular Carcinoma.

|Jun 01, 2026
EP4 Antagonist ONO-4578 Plus Nivolumab and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Negative Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer.

|Apr 06, 2026
Predictive Value of Insertion/Deletion Rate in Patients With Gastric Cancer Treated With Nivolumab Plus Chemotherapy.

Hyung-Don Kim, Hyungeun Lee, Sun Young Lee

|Apr 06, 2026
Gastrointestinal Stromal Tumor: History, Molecular Subtypes, and Risk Stratification.

In Hye Song, Soomin Ahn, Hyung-Don Kim

|Jan 28, 2026
Association between the presence of malignant ascites and survival outcomes in gastric cancer patients treated with nivolumab plus chemotherapy.

Yuna Lee, Hyung-Don Kim, Hyungeun Lee

Pageof 5

Frequent Collaborators

9 joint publications

Hyung-Don Kim

4 joint publications

Changhoon Yoo

4 joint publications

Young Soo Park

3 joint publications

Sun Young Rha